Close
0
Inquiry Basket

There is no product in the shopping cart, buy it!

Hot Products
Monosaccharide Products
Oligosaccharide Products
Polysaccharide Products
Carbohydrate-based Surfactant Products
Blood Group Antigen Products
Glycoprotein Products
Glycopeptide Products
Nucleotide Sugar Products
Glycoprotein Assay Kits
Comprehensive Glycoprotein Reagents
Glycoengineered Cell Products
Glycoengineering Viral Particle Products
Glycolipid Products

Recombinant Human Biglycan (BGN) protein, Insect cell line

CAT#: GP01-026J

Datasheet Request COA
Specifications Target Information Related Products
Specifications
Product Overview
Recombinant Human Biglycan (BGN) protein (NP_001702) was expressed in Insect cell line. The biological activity was determined by its binding ability in a functional ELISA. This product can be used in ELISA, WB, IP.
Biological Activity
Determined by its binding ability in a functional ELISA.
Source
Insect cell line
Species
Human
Predicted MW
38.3 KDa
Purity
>90%, determined by SDS-PAGE and HPLC
Conjugation
Unconjugated
Target Information
Target
BGN
Full Name
Biglycan
Gene ID
633
Uniprot ID
P21810
Accession Number
NP_001702
Background
This gene encodes a member of the small leucine-rich proteoglycan (SLRP) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein, which plays a role in bone growth, muscle development and regeneration, and collagen fibril assembly in multiple tissues. This protein may also regulate inflammation and innate immunity. Additionally, the encoded protein may contribute to atherosclerosis and aortic valve stenosis in human patients. This gene and the related gene decorin are thought to be the result of a gene duplication.
Alternate Names
PGI; MRLS; DSPG1; PG-S1; SEMDX; SLRR1A; BGN; Biglycan
For Research Use Only.
Online Inquiry
Copyright © Creative Biolabs. All Rights Reserved.